MARKET

ACON

ACON

Aclarion Inc
NASDAQ
6.10
+0.20
+3.39%
Opening 10:20 12/18 EST
OPEN
6.00
PREV CLOSE
5.90
HIGH
6.17
LOW
5.90
VOLUME
65.18K
TURNOVER
--
52 WEEK HIGH
3,499.51
52 WEEK LOW
5.55
MARKET CAP
4.10M
P/E (TTM)
-0.0036
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACON last week (1208-1212)?
Weekly Report · 3d ago
Weekly Report: what happened at ACON last week (1201-1205)?
Weekly Report · 12/08 10:02
Aclarion announces publication of Nociscan article in pain issue of IJSS
TipRanks · 12/04 13:15
Aclarion Nociscan Study Published in Leading Spine Surgery Journal
Reuters · 12/04 13:11
Aclarion Announces Publication Of Featured Article Tech Update In Upcoming Special Pain Issue Of The International Journal Of Spine Surgery
Benzinga · 12/04 13:05
Aclarion appoints Jason Brosniak as commercial director, Eastern U.S.
TipRanks · 12/02 13:10
Press Release: Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.
Dow Jones · 12/02 13:00
Aclarion CEO Brent Ness Reports Acquisition of Common Shares
Reuters · 12/01 22:00
More
About ACON
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.

Webull offers Aclarion Inc stock information, including NASDAQ: ACON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACON stock methods without spending real money on the virtual paper trading platform.